Nachrichten zur Halozyme Therapeutics Inc. Aktie

Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of 2.13% and 2.46%, respectively, for the quarter ended December 2022. Do…

Investors need to pay close attention to Halozyme (HALO) stock based on the movements in the options market lately....…

Though Halozyme (HALO) expects a year-over-year increase in revenues and earnings for 2023, the companys guidance fell short of Wall…

SAN DIEGO, Jan. 11, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that it has elected to…

Halozyme Therapeutics Stock Down 8% on 2022, 2023 Revenue Guidance...…

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Halozyme Therapeutics Inc. HALO stock fell in the extended session Tuesday after the biotech drug maker’s 2023 forecast disappointed Wall…

2023 Total Revenue Guidance of $815 to $845 Million Representing >20% Growth Over Expected 2022 Revenue 2023 Recurring Revenues from…

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…